Study finds possible alternative abortion pill
An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
What happened
Researchers reported Thursday that a 60 milligram dose of ulipristal acetate, the active ingredient in the prescription emergency contraceptive Ella, appeared to be as safe and effective at ending a pregnancy as the abortion medication mifepristone.
The study, involving 133 women in the first nine weeks of pregnancy, was published in the journal NEJM Evidence.
Who said what
Dr. Beverly Winikoff, president of Gynuity Health Projects and lead author of the study, said abortion bans and efforts to bar mifepristone started her searching for more options. With the ulipristal and a later dose of misoprostol, "at least now we would have an alternative," she told The Associated Press.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Mifepristone, "now used in two-thirds of U.S. abortions," has been "under attack by abortion opponents" since Roe v. Wade was struck down, the AP said, and the new study "may make emergency contraception a target" as well. Drugmaker Perrigo said the prescribed 30 mg dose of Ella prevents but cannot end pregnancies. The "much more widely used morning-after pill" Plan B "contains a different drug and does not work in a way that would terminate a pregnancy, according to scientific evidence," The New York Times said.
What next?
The "political implications of the study are complex," the Times said. Evidence that a "morning-after pill ingredient can be used for abortion," as abortion opponents have long said, could "sow confusion" and "bolster the larger anti-abortion strategy," but banning contraception is deeply unpopular across the board.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Political cartoons for October 26Cartoons Sunday’s editorial cartoons include Young Republicans group chat, Louvre robbery, and more
-
Why Britain is struggling to stop the ransomware cyberattacksThe Explainer New business models have greatly lowered barriers to entry for criminal hackers
-
Greene’s rebellion: a Maga hardliner turns against TrumpIn the Spotlight The Georgia congresswoman’s independent streak has ‘not gone unnoticed’ by the president
-
Climate change is getting under our skinUnder the radar Skin conditions are worsening because of warming temperatures
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Forever chemicals were found in reusable menstrual products. That is nothing new for women.Under the Radar Toxic chemicals are all too common in such products
-
Food may contribute more to obesity than exerciseUnder the radar The devil's in the diet
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
